High levels of plasma IL-1β and tumor-derived IL-1β significantly correlate with tumor invasiveness and bone metastasis in BrCa and PrCa, which translates into a poor prognosis [151,152,153,154,155]. This evidence concerns the gene IL1B and neoplasm.